Researchers at the University of Miami Miller School of Medicine have released a sobering analysis of alcohol‑related cancer mortality in the United States. Using more than three decades of data from the Global Burden of Disease study, the team found that estimated annual deaths attributable to alcohol more than doubled, climbing from 11,361 in 1990 to 23,126 in 2023.
Key findings by age and sex
The study, published in The Lancet Regional Health – Americas and presented at the American Society of Clinical Oncology meeting in Chicago, highlights several important patterns. Overall, older adults and men bore the greatest burden, but younger Americans showed a distinct shift in the cancers most linked to alcohol.
For men ages 20‑54, colorectal cancer emerged as the top alcohol‑attributable cancer cause in 2023. Among women in the same age group, breast cancer ranked first, with colorectal cancer in second place. This contrasts with the public’s common association of alcohol primarily with liver disease and liver cancer.
Broader cancer impact
Dr. Chinmay Jani, the study’s corresponding author and chief fellow in hematology and oncology at the Sylvester Comprehensive Cancer Center, emphasized the breadth of alcohol’s impact. “The most surprising finding was the breadth of alcohol’s potential impact across cancer types,” Jani said. While liver cancer remains the leading alcohol‑linked cancer among older men, the data show significant contributions from esophageal, colorectal, pancreatic, and prostate cancers as well.
Women overall experienced breast cancer as the leading alcohol‑attributable cancer, followed by colorectal and other sites. Notably, the age‑standardized mortality rate for alcohol‑related cancer rose from 3.8 deaths per 100,000 people in 1990 to 4.1 in 2023. The increase was driven by men, while the rate for women showed a modest decline over the same period.
Geographic variation
The analysis also uncovered stark geographic differences. The District of Columbia recorded the highest age‑standardized mortality rate at 9.8 deaths per 100,000, whereas Utah reported the lowest rates nationwide.
Understanding the limitations
Researchers caution that the study does not prove alcohol caused every cancer death counted. The analysis relied on population‑level data and statistical modeling rather than tracking individual drinking habits or medical histories. Consequently, the findings demonstrate an association, not a direct causal link for any single case.
Dr. Gilberto Lopes, senior author and chief of the Division of Medical Oncology at the University of Miami, stressed the practical takeaway: “As physicians and cancer researchers, we have an opportunity to help patients understand that alcohol is a modifiable risk factor.” He noted that even modest, informed reductions in alcohol consumption could become part of a broader strategy to lower long‑term cancer risk.
Public awareness and next steps
The International Agency for Research on Cancer classifies alcohol as a Group 1 carcinogen, meaning there is sufficient evidence that alcohol consumption can cause cancer in humans. Yet public awareness of this risk remains far behind the recognition of tobacco’s dangers. Researchers hope the new data will encourage more informed conversations about drinking habits and cancer prevention.
While the study does not specify a “safe” level of alcohol intake, it reinforces the message that reducing consumption is a potentially effective way to mitigate cancer risk. Health professionals are urged to incorporate these findings into patient counseling and public‑health messaging.
Original reporting: WOWO News/Talk (Fort Wayne) — read the source article.
